Cancer-related inflammation is one of the hallmarks of cancer [32], and interleukin-1 (IL-1), IL-6, tumor necrosis factor alpha (TNF-α), and C-reactive protein (CRP) are widely recognized as biomarkers of systemic inflammation related to breast cancer [33]. This evidence concerns the gene CRP and breast carcinoma.